Acasti Pharma | ACST - PE Price to Earnings

Stock Price
2.16
Daily Change
-0.03 -1.37%
Monthly
-51.89%
Yearly
-22.86%
Q2 Forecast
2.12

Acasti Pharma reported 9.94 in PE Price to Earnings for its fiscal quarter ending in March of 2021.





Pe Change Date
Acasti Pharma 9.94 0.08 Mar/2021
Addus HomeCare 15.67 3.24 Mar/2026
Amarin 91.05 88.3 Jun/2023
Knight Therapeutics 257.34 166.24 Dec/2025
Option Care Health 25.07 3.02 Dec/2025
Organigram Holdings 235 224.49 Sep/2025
Tilray 11.56 80.19 Sep/2025